Kythera Biopharmaceuticals, Inc. (KYTH) in Focus: Stock Surges 9.9 % - Tale of the Tape - ANI Pharmaceuticals (NASDAQ:ANIP)

Kythera Biopharmaceuticals, Inc. KYTH was a big mover last session, as the company saw its shares rise nearly 10% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is now down about 22.8% in the past one-month time frame.

In the last 30 days, the company witnessed 1 downward estimate revision and the Zacks Consensus Estimate of a loss widened, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.

Kythera Biopharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Other better-ranked players in the healthcare industry include Myriad Genetics Inc. MYGN, ANI Pharmaceuticals, Inc. ANIP and Aastrom Biosciences, Inc. ASTM all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ANI PHARMACEUT ANIP: Free Stock Analysis Report

AASTROM BIOSCI ASTM: Get Free Report

KYTHERA BIOPHRM KYTH: Free Stock Analysis Report

MYRIAD GENETICS MYGN: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs